A randomized, double-blind, placebo-controlled, phase 3 study to evaluate the efficacy, safety, and tolerability of JNJ-27018966 in the treatment of patients with diarrhea-predominant irritable bowel syndrome,
Role: Investigator,
Furiex Pharmaceuticals,
(07/2012 - 07/2013)
Status: Completed
Internal
Are Bone Turnover Markers Associated With Frequency of Complete Denture relines?,
Role: Co-Investigator,
LLU - GRASP,
(11/2013 - 11/2014)
Status: Closed
Radiofrequency ablation (RFA) using HALO device vs Argon plasma coagulation (APC) for GAVE (gastric antral vascular ectasia) lesions,
Role: Investigator,
LLU Dept. of Gastroenterology,
(07/2013 - 06/2014)
Status: Completed